These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10162421)

  • 21. Utility Values for Health States in Ireland: A Value Set for the EQ-5D-5L.
    Hobbins A; Barry L; Kelleher D; Shah K; Devlin N; Goni JMR; O'Neill C
    Pharmacoeconomics; 2018 Nov; 36(11):1345-1353. PubMed ID: 30051267
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Health-state valuations for pertussis: methods for valuing short-term health states.
    Lee GM; Salomon JA; LeBaron CW; Lieu TA
    Health Qual Life Outcomes; 2005 Mar; 3():17. PubMed ID: 15780145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of United States and United Kingdom EQ-5D health states valuations using a nonparametric Bayesian method.
    Kharroubi SA; O'Hagan A; Brazier JE
    Stat Med; 2010 Jul; 29(15):1622-34. PubMed ID: 20209481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is there a case for using visual analogue scale valuations in cost-utility analysis?
    Parkin D; Devlin N
    Health Econ; 2006 Jul; 15(7):653-64. PubMed ID: 16498700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mapping visual analogue scale health state valuations onto standard gamble and time trade-off values.
    Dolan P; Sutton M
    Soc Sci Med; 1997 May; 44(10):1519-30. PubMed ID: 9160441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A social preference valuations set for EQ-5D health states in Flanders, Belgium.
    Cleemput I
    Eur J Health Econ; 2010 Apr; 11(2):205-13. PubMed ID: 19582490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Individual differences in the use of the response scale determine valuations of hypothetical health states: an empirical study.
    Essink-Bot ML; Stuifbergen MC; Meerding WJ; Looman CW; Bonsel GJ;
    BMC Health Serv Res; 2007 Apr; 7():62. PubMed ID: 17466068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How dead is dead? Qualitative findings from participants of combined traditional and lead-time time trade-off valuations.
    Al Sayah F; Mladenovic A; Gaebel K; Xie F; Johnson JA
    Qual Life Res; 2016 Jan; 25(1):35-43. PubMed ID: 26216584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic evaluation in schistosomiasis: valuation of health states preferences. A research note.
    Kirigia JM
    Health Econ; 1998 Sep; 7(6):551-6. PubMed ID: 9809712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Comparison of Japan and U.K. SF-6D Health-State Valuations Using a Non-Parametric Bayesian Method.
    Kharroubi SA
    Appl Health Econ Health Policy; 2015 Aug; 13(4):409-20. PubMed ID: 25896874
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of scoring weights for the EuroQol derived from patients and the general public.
    Polsky D; Willke RJ; Scott K; Schulman KA; Glick HA
    Health Econ; 2001 Jan; 10(1):27-37. PubMed ID: 11180567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Valuing Health Using Time Trade-Off and Discrete Choice Experiment Methods: Does Dimension Order Impact on Health State Values?
    Mulhern B; Shah K; Janssen MF; Longworth L; Ibbotson R
    Value Health; 2016; 19(2):210-7. PubMed ID: 27021755
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time trade-off and ranking exercises are sensitive to different dimensions of EQ-5D health states.
    Rand-Hendriksen K; Augestad LA
    Value Health; 2012; 15(5):777-82. PubMed ID: 22867789
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The gap effect: discontinuities of preferences around dead.
    Stalmeier PF; Busschbach JJ; Lamers LM; Krabbe PF
    Health Econ; 2005 Jul; 14(7):679-85. PubMed ID: 15744750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Testing the interval-level measurement property of multi-item visual analogue scales.
    Krabbe PF; Stalmeier PF; Lamers LM; Busschbach JJ
    Qual Life Res; 2006 Dec; 15(10):1651-61. PubMed ID: 17031501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Valuation of preference-based measures: can existing preference data be used to generate better estimates?
    Kharroubi SA
    Health Qual Life Outcomes; 2018 Jun; 16(1):116. PubMed ID: 29866108
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Using the Analytic Hierarchy Process to Derive Health State Utilities from Ordinal Preference Data.
    Reddy BP; Adams R; Walsh C; Barry M; Kind P
    Value Health; 2015 Sep; 18(6):841-5. PubMed ID: 26409612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reconsidering the use of rankings in the valuation of health states: a model for estimating cardinal values from ordinal data.
    Salomon JA
    Popul Health Metr; 2003 Dec; 1(1):12. PubMed ID: 14687419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Valuation of EuroQol Five-Dimensional Questionnaire, Youth Version (EQ-5D-Y) and EuroQol Five-Dimensional Questionnaire, Three-Level Version (EQ-5D-3L) Health States: The Impact of Wording and Perspective.
    Kreimeier S; Oppe M; Ramos-Goñi JM; Cole A; Devlin N; Herdman M; Mulhern B; Shah KK; Stolk E; Rivero-Arias O; Greiner W
    Value Health; 2018 Nov; 21(11):1291-1298. PubMed ID: 30442276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimating an EQ-5D-5L Value Set for China.
    Luo N; Liu G; Li M; Guan H; Jin X; Rand-Hendriksen K
    Value Health; 2017 Apr; 20(4):662-669. PubMed ID: 28408009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.